Neurological Biomarkers Market Size to Achieve USD 18.9 billion by 2031, Fueled by a CAGR of 13.6%: Says AMR

A new business intelligence report released by Allied Market Research, the global Neurological Biomarkers Market size was estimated at $5.4 billion in 2021 and is expected to hit $18.9 billion by 2031, registering a CAGR of 13.6% from 2022 to 2031. The report provides a detailed analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive landscape, and evolving market trends. The market study is a helpful source of information for the frontrunners, new entrants, investors, and shareholders in crafting strategies for the future and heightening their position in the market.

What are the factors driving the Neurological Biomarkers Market?

Rise in the prevalence of neurological diseases such as Huntington's disease, schizophrenia, Parkinson's disease, Alzheimer's disease, and others drives the growth of the global neurological biomarkers market. Based on application, the Alzheimer's disease segment held the major share in 2021. By region, on the other hand, Asia-Pacific would cite the fastest CAGR by 2031.

Get Sample PDF Report with Graphs and Figures Here: https://www.alliedmarketresearch.com/request-sample/3555

Top Neurological Biomarkers Companies

The key market players analyzed in the global neurological biomarkers market report include Bio-Rad Laboratories, Inc., Biomérieux, F. Hoffmann-La Roche Ltd., Myriad Genetics, Inc., Perkinelmer Inc., Quanterix, Shimadzu Corporation, Neurobio, Merck KGAA, and Thermo Fisher Scientific, Inc. These market players have embraced several strategies including partnership, expansion, collaboration, joint ventures, and others to highlight their prowess in the industry. The report is helpful in formulating the business performance, product portfolio, operating segments, and developments by the top players.

Neurological Biomarkers Market segmentation can be done based on several factors, including:

The global neurological biomarkers market is analyzed across type, application, and region. The report takes in an exhaustive analysis of the segments and their sub-segments with the help of tabular and graphical representation. Investors and market players can benefit from the breakdown and devise stratagems based on the highest revenue-generating and fastest-growing segments stated in the report.
Based on type, the proteomic segment held more than one-fourth of the total market revenue in 2021, and is expected to dominate by 2031. The same segment would also manifest the fastest CAGR of 14.1% throughout the forecast period.

Based on application, the Alzheimer's disease segment garnered more than half of the total market revenue in 2021, and is expected to dominate by 2031. The same segment would also project the fastest CAGR of 13.8% throughout the forecast period.

Based on region, the global neurological biomarkers market across North America generated more than half of the total market revenue in 2021, and is anticipated to retain the lion's share by 2031. The Asia-Pacific region, on the other hand, would also showcase the fastest CAGR of 8.7% during the forecast period. The other provinces analyzed through the report include Europe and LAMEA.

Purchase the Report: https://www.alliedmarketresearch.com/purchase-enquiry/3555

By Region Outlook

• North America
(U.S., Canada, Mexico)
• Europe
(Germany, France, UK, Italy, Spain, Rest of Europe)
• Asia-Pacific
(Japan, China, India, Rest of Asia-Pacific)
• LAMEA
(Brazil, Saudi Arabia, South Africa, Rest of LAMEA)

Our Market Research Solution Provides You Answer to Below Mentioned Question:

• Which are the driving factors responsible for the growth of market?
• Which are the roadblock factors of this market?
• What are the new opportunities, by which market will grow in coming years?
• What are the trends of this market?
• Which are main factors responsible for new product launch?
• How big is the global & regional market in terms of revenue, sales and production?
• How far will the market grow in forecast period in terms of revenue, sales and production?
• Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
• How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?
• Which region has more opportunities?

Contact Details:

David Correa
USA/Canada (Toll-Free): +1-800-792-5285, +1-503-894-6022
help@alliedmarketresearch.com

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

This release was published on openPR.